Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.080 | Biomarker | group | BEFREE | The combination of 13N-ammonia and 18F-FDG PET/CT in the identification of metabolic phenotype of primary human brain tumors. | 30995685 | 2019 | ||||
|
0.080 | Biomarker | group | BEFREE | Vice versa, highly F-FDG-avid lung lesions in patients with brain tumors should lead to distant metastases as differential diagnosis despite their rare occurrence. | 31584491 | 2019 | ||||
|
0.080 | Biomarker | group | BEFREE | The present study indicated that gadolinium-enhanced MRI combined with 18F-FDG PET/CT and laboratory examinations are helpful in distinguishing cerebral syphilitic gumma from brain tumors and infectious diseases, therefore avoiding unnecessary surgery. | 31772624 | 2019 | ||||
|
0.080 | Biomarker | group | BEFREE | O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine ([<sup>18</sup>F]FET) is the most promising radio-labeled amino acid tracer for brain tumor imaging due to the limitation of 2-deoxy-2-[<sup>18</sup>F]fluoro-D-glucose ([<sup>18</sup>F]FDG) and L-methyl-[<sup>11</sup>C]methionine (<sup>11</sup>C-MET). | 29275040 | 2018 | ||||
|
0.080 | Biomarker | group | BEFREE | The limitations of [<sup>18</sup>F]fluorodeoxyglucose ([<sup>18</sup>F]FDG), including producing false-positive or -negative results, low image contrast in brain tumor diagnosis and poor differentiation of tumor and inflammatory, necessitate the development of new radiopharmaceuticals. | 30248568 | 2018 | ||||
|
0.080 | Biomarker | group | BEFREE | Reduced FDG uptake in ipsilateral TH and contralateral CE usually occur simultaneously in patients with solitary brain tumors. | 29372376 | 2018 | ||||
|
0.080 | Biomarker | group | BEFREE | The results support that [<sup>18</sup>F]FPDOPA seems to be a potential PET tracer for tumor imaging, especially be a better potential PET tracer than [<sup>18</sup>F]fluoro-2-deoxy-d-glucose ([<sup>18</sup>F]FDG) for brain tumor imaging. | 28456080 | 2017 | ||||
|
0.080 | Biomarker | group | BEFREE | A previous review published in 2012 demonstrated the role of clinical PET for diagnosis and management of brain tumors using mainly FDG, amino acid tracers, and <sup>18</sup>F-fluorothymidine. | 27987557 | 2017 |